The Medical Radiation Shielding Market is becoming increasingly important as healthcare providers expand the use of diagnostic imaging, radiation therapy, nuclear medicine, and other procedures involving ionizing radiation. Radiation shielding solutions are designed to protect patients, healthcare professionals, technicians, and surrounding environments from unnecessary radiation exposure. According to Market Research Future, the global market was valued at USD 1.71 billion in 2025 and is projected to reach USD 3.39 billion by 2035, registering a CAGR of 7.1%.

The increasing global cancer burden is one of the major factors supporting market development. Cancer treatment frequently involves radiation therapy, while diagnosis and treatment planning increasingly depend on X-ray, CT, PET, and other imaging technologies. As healthcare facilities install additional imaging and radiation therapy systems, demand for appropriately designed shielding rooms, barriers, doors, windows, and protective materials continues to increase.

Hospitals represent a major end-user category because they accommodate large numbers of imaging systems, linear accelerators, PET scanners, fluoroscopy equipment, and nuclear medicine facilities. Market Research Future estimates that hospitals accounted for approximately 66% of the market in 2025. Diagnostic radiology also represented the largest imaging and therapy modality segment, with around 58% of revenue.

Material innovation is another important market trend. Lead-based shielding remains dominant because of its established performance, regulatory acceptance, and cost-effectiveness. However, non-lead composites are gaining attention because they can reduce structural weight while addressing environmental and disposal concerns associated with conventional lead materials. Bismuth-, barium-, and boron-based formulations are being explored for healthcare construction and retrofit projects.

The expansion of proton and heavy-ion therapy facilities is creating additional opportunities. These treatment centers require substantial shielding because of the high-energy radiation generated during treatment. The growing number of radiopharmaceutical production facilities and hot-cell installations is also increasing demand for specialized shielding systems.

North America maintained a leading position, accounting for approximately 38% of global revenue in 2025, while Asia-Pacific is expected to experience strong growth through 2035. Increasing healthcare infrastructure investment, oncology capacity expansion, and adoption of advanced imaging technologies across emerging economies are supporting regional opportunities.

Overall, the market is moving toward lighter materials, modular shielding systems, advanced design technologies, and integrated engineering solutions. These developments are expected to strengthen radiation protection while improving installation efficiency and supporting the expansion of modern healthcare infrastructure.